Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans

被引:47
作者
Lenzlinger, PM
Marx, A
Trentz, O
Kossmann, T
Morganti-Kossmann, MC
机构
[1] Univ Hosp, Div Trauma Surg, Dept Surg, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Surg, Div Surg Res, CH-8091 Zurich, Switzerland
[3] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA
关键词
brain injuries; apoptosis; cerebrospinal fluid; soluble Fas (CD95); blood-brain barrier; neuron-specific enolase; inflammation;
D O I
10.1016/S0165-5728(01)00466-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The mechanisms underlying cell death following traumatic brain injury (TBI) are not fully understood. Apoptosis is believed to be one mechanism contributing to a marked and prolonged neuronal cell loss following TBL Recent data suggest a role for Fas (APO-1, CD95), a type I transmembrane receptor glycoprotein of the nerve growth factor/tumor necrosis factor superfamily, and its ligand (Fas ligand, FasL) in apoptotic events in the central nervous system. A truncated form of the Fas receptor, soluble Fas (sFas) may indicate activation of the Fas/FasL system and act as a negative feedback mechanism, thereby inhibiting Fas mediated apoptosis. Soluble Fas was measured in cerebrospinal fluid (CSF) and serum of 10 patients with severe TBI (GCS less than or equal to 8) for up to 15 days post-trauma. No sFas was detected in CSF samples from patients without neurological pathologies. Conversely, after TBI 118 out of 120 CSF samples showed elevated sFas concentrations ranging from 56 to 4327 mU/ml. Paired serum samples showed above normal (8.5 U/ml) sFas, concentrations in 5 of 10 patients. Serum levels of sFas were always higher than CSF levels. However, there was no correlation between concentrations measured in CSF and in serum (r(2) = 0.078, p = 0.02), suggesting that the concentrations in the two compartments are independently regulated. Also, no correlation was found between sFas in CSF and blood brain barrier (BBB) dysfunction as assessed by the albumin CSF/serum quotient (Q(A)), and concentrations of the cytotoxic cytokine tumor necrosis factor-alpha in CSF, respectively. Furthermore, there was no correlation with two markers of immune activation (soluble interleukin-2 receptor and neopterin) in CSF. Maximal CSF levels of sFas correlated significantly (r(2)=0.8191, p<0.001) with the early peaks of neuron-specific enolase in CSF (a marker for neuronal cell destruction), indicating that activation of the Fas mediated pathway of apoptosis may be in part the direct result of the initial trauma. However, the prolonged elevation of sFas in CSF may be caused by the ongoing inflammatory response to trauma and delayed apoptotic cell death. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 70 条
[1]   Die and let live: Eliminating dangerous lymphocytes [J].
Abbas, AK .
CELL, 1996, 84 (05) :655-657
[2]   ALTERED IMMUNOEXPRESSION OF MICROGLIA AND MACROPHAGES AFTER MILD HEAD-INJURY [J].
AIHARA, N ;
HALL, JJ ;
PITTS, LH ;
FUKUDA, K ;
NOBLE, LJ .
JOURNAL OF NEUROTRAUMA, 1995, 12 (01) :53-63
[3]  
ARENDS MJ, 1991, INT REV EXP PATHOL, V32, P223
[4]   CD95-CD95L: can the brain learn from the immune system? [J].
Becher, B ;
Barker, PA ;
Owens, T ;
Antel, JP .
TRENDS IN NEUROSCIENCES, 1998, 21 (03) :114-117
[5]  
Bechmann I, 2000, GLIA, V32, P25, DOI 10.1002/1098-1136(200010)32:1<25::AID-GLIA30>3.0.CO
[6]  
2-Y
[7]  
Bechmann I, 1999, GLIA, V27, P62, DOI 10.1002/(SICI)1098-1136(199907)27:1<62::AID-GLIA7>3.0.CO
[8]  
2-S
[9]   Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat [J].
Beer, R ;
Franz, G ;
Schöpf, M ;
Reindl, M ;
Zelger, B ;
Schmutzhard, E ;
Poewe, W ;
Kampfl, A .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2000, 20 (04) :669-677
[10]  
Bouma G J, 1995, New Horiz, V3, P384